Pär Gerwins

4.9k total citations
60 papers, 4.1k citations indexed

About

Pär Gerwins is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Pär Gerwins has authored 60 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 15 papers in Immunology and 11 papers in Oncology. Recurrent topics in Pär Gerwins's work include Angiogenesis and VEGF in Cancer (11 papers), Protein Kinase Regulation and GTPase Signaling (8 papers) and Adenosine and Purinergic Signaling (8 papers). Pär Gerwins is often cited by papers focused on Angiogenesis and VEGF in Cancer (11 papers), Protein Kinase Regulation and GTPase Signaling (8 papers) and Adenosine and Purinergic Signaling (8 papers). Pär Gerwins collaborates with scholars based in Sweden, United States and Switzerland. Pär Gerwins's co-authors include Gary L. Johnson, Lena Claesson‐Welsh, Christian Widmann, Matthew Jarpe, B.B. Fredholm, Natalie J. Avdi, Jerry A. Nick, Witold W. Kilarski, Erik Sköldenberg and Gary R. Fanger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Pär Gerwins

58 papers receiving 4.0k citations

Peers

Countries citing papers authored by Pär Gerwins

Since Specialization

Citations

This map shows the geographic impact of Pär Gerwins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pär Gerwins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pär Gerwins more than expected).

Fields of papers citing papers by Pär Gerwins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pär Gerwins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pär Gerwins. The network helps show where Pär Gerwins may publish in the future.

Co-authorship network of co-authors of Pär Gerwins

This figure shows the co-authorship network connecting the top 25 collaborators of Pär Gerwins. A scholar is included among the top collaborators of Pär Gerwins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pär Gerwins. Pär Gerwins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Massive Chylous Ascites in a 9-Year-Old Girl with Malrotation—A Case Report 2023 ·SHILAP Revista de lepidopterología ·(unknown), Pär Gerwins, (unknown)	0
2	Activated platelets contribute to the progression of hepatocellular carcinoma by altering the tumor environment 2021 ·Life Sciences ·Nataša Pavlović, (unknown), Pär Gerwins, Femke Heindryckx	19
3	FGD5 sustains vascular endothelial growth factor A (VEGFA) signaling through inhibition of proteasome-mediated VEGF receptor 2 degradation 2017 ·Cellular Signalling ·Johan Heldin, P.W. O’Callaghan, (unknown), Peder Fredlund Fuchs, Pär Gerwins, Johan Kreuger	19
4	The novel alkylating prodrug melflufen (J1) inhibits angiogenesis in vitro and in vivo 2013 ·Biochemical Pharmacology ·(unknown), Malin Wickström, Peder Fredlund Fuchs, Mårten Fryknäs, Pär Gerwins, (unknown), Rolf Larsson, Joachim Gullbo	31
5	Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1 2009 ·Genome Medicine ·Erik Larsson, Peder Fredlund Fuchs, Johan Heldin, Irmeli Barkefors, Cecilia Bondjers, Guillem Genové, Christelle Arrondel, Pär Gerwins, Christine Kurschat, Bernhard Schermer, Thomas Benzing, Scott J. Harvey, Johan Kreuger, Per Lindahl	78
6	Biomechanical regulation of blood vessel growth during tissue vascularization 2009 ·Nature Medicine ·Witold W. Kilarski, Branka Samolov, (unknown), Anders Kvanta, Pär Gerwins	177
7	An ex vivo model for functional studies of myofibroblasts 2005 ·Laboratory Investigation ·Witold W. Kilarski, Natalia Jura, Pär Gerwins	19
8	Efficient Human Interferon-α Gene Transfer to Neuroendocrine Tumor Cells with Long-Term and Stable Expression 2005 ·Neuroendocrinology ·(unknown), Witold W. Kilarski, Pär Gerwins, Kjell Öberg, Yinghua Zhou	3
9	Increased brain injury and vascular leakage after pretreatment with p38-inhibitor SB203580 in transient ischemia 2003 ·Acta Neurologica Scandinavica ·Fredrik Lennmyr, Anders Ericsson, Pär Gerwins, Håkan Åhlström, Andreas Terént	43
10	Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis 2000 ·Critical Reviews in Oncology/Hematology ·Pär Gerwins, Erik Sköldenberg, Lena Claesson‐Welsh	223
11	Differential activation and regulation of mitogen-activated protein kinases through the antigen receptor and CD40 in human B cells 1999 ·European Journal of Immunology ·Naoaki Sakata, Hideki Kawasome, Naohiro Terada, Pär Gerwins, Gary L. Johnson, Erwin W. Gelfand	29
12	Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells. 1998 ·PubMed ·Tamotsu Ishizuka, Hideki Kawasome, Naohiro Terada, Katsuyuki Takeda, Pär Gerwins, Gordon Keller, Gary L. Johnson, Erwin W. Gelfand	48
13	Stem Cell Factor Augments FcεRI-Mediated TNF-α Production and Stimulates MAP Kinases via a Different Pathway in MC/9 Mast Cells 1998 ·The Journal of Immunology ·Tamotsu Ishizuka, Hideki Kawasome, Naohiro Terada, Katsuyuki Takeda, Pär Gerwins, Gordon Keller, Gary L. Johnson, Erwin W. Gelfand	44
14	Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. 1997 ·Journal of Clinical Investigation ·Jerry A. Nick, Natalie J. Avdi, S K Young, Cindy Knall, Pär Gerwins, Gary L. Johnson, G. Scott Worthen	265
15	Cloning of a Novel Mitogen-activated Protein Kinase Kinase Kinase, MEKK4, That Selectively Regulates the c-Jun Amino Terminal Kinase Pathway 1997 ·Journal of Biological Chemistry ·Pär Gerwins, (unknown), Gary L. Johnson	206
16	Fc gamma receptor cross-linking activates p42, p38, and JNK/SAPK mitogen-activated protein kinases in murine macrophages: role for p42MAPK in Fc gamma receptor-stimulated TNF-alpha synthesis 1997 ·The Journal of Immunology ·David M. Rose, Brent W. Winston, Edward D. Chan, David W. H. Riches, Pär Gerwins, Gary L. Johnson, Peter M. Henson	91
17	Activation of adenosine A1 and bradykinin receptors increases protein kinase C and phospholipase D activity in smooth muscle cells 1995 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Pär Gerwins, (unknown)	33
18	Modification of a Competitive Protein Binding Assay for Determination of Inositol 1,4,5-Trisphosphate 1993 ·Analytical Biochemistry ·Pär Gerwins	16
19	Glucocorticoid receptor activation leads to up-regulation of adenosine A1 receptors and down-regulation of adenosine A2 responses in DDT1 MF-2 smooth muscle cells. 1991 ·Molecular Pharmacology ·Pär Gerwins, B.B. Fredholm	53
20	Stimulation of the T-cell receptors CD3 and CD2 with OKT3 and OKT11 antibodies activates a common pertussis toxin-insensitive G-protein 1990 ·European Journal of Pharmacology Molecular Pharmacology ·Anders Kvanta, Pär Gerwins, Ingeborg van der Ploeg, Christer Nordstedt, Mikael Jondal, Bertil B. Fredholm	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact